$4.40
0.12[2.80%]
At close: Apr 16
$4.40
0[0.00%]
After Hours: 6:09AM EDT
Moleculin Biotech
(NASDAQ:MBRX)Moleculin Biotech Stock (NASDAQ:MBRX), Quotes and News Summary
Moleculin Biotech Stock (NASDAQ: MBRX) stock price, news, charts, stock research, profile.
| Open | $4.320 |
| Close | $4.280 |
| Volume / Avg. | 10.408K / 33.336K |
| Day Range | 4.280 - 4.420 |
| 52 Wk Range | 4.280 - 24.750 |
| Market Cap | $9.801M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 29 |
| Short Interest | 2.09% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Moleculin Biotech Inc
Sector
Health Care
Industry
Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a bro...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Moleculin Biotech (MBRX) stock?
You can purchase shares of Moleculin Biotech (NASDAQ: MBRX) through any online brokerage.
Who are Moleculin Biotech's (MBRX) competitors?
Other companies in Moleculin Biotech’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Can Fite Biofarma (AMEX:CANF).
What is the target price for Moleculin Biotech (MBRX) stock?
The latest price target for Moleculin Biotech (NASDAQ: MBRX) was reported by Roth MKM on Friday, April 12, 2024. The analyst firm set a price target for 40.00 expecting MBRX to rise to within 12 months (a possible 809.09% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Moleculin Biotech (MBRX)?
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $4.4 last updated April 16, 2024 at 6:09 AM EDT.
Does Moleculin Biotech (MBRX) pay a dividend?
There are no upcoming dividends for Moleculin Biotech.
When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?
Moleculin Biotech’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Moleculin Biotech (MBRX) going to split?
There is no upcoming split for Moleculin Biotech.
What sector and industry does Moleculin Biotech (MBRX) operate in?
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.